博雅生物：截至目前，公司未有股份回购的计划

Group 1 - The company acknowledges the impact of macroeconomic environment, industry policies, and investor risk preferences on its stock price [1] - The company is committed to improving profitability and has implemented a prudent dividend policy to reward shareholders [1] - Currently, the company has no plans for stock buybacks despite investor concerns regarding stock price decline and low dividends [1]